Intestinal non-Hodgkin's lymphoma: A multicenter prospective clinical study from the German Study Group on intestinal non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 21, Issue 14, 2003, Pages 2740-2746

  Daum, Severin ^a   Ullrich, Reiner ^a   Heise, Walter ^a   Dederke, Bettina ^a   Foss, Hans Dieter ^a   Stein, Harald ^a   Thiel, Eckhard ^a   Zeitz, Martin ^a   Riecken, Ernst Otto ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT; VAP CYCLO PROTOCOL; VAP-CYCLO PROTOCOL;

ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; HUMAN; INTESTINE LYMPHOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL; T CELL LYMPHOMA; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GERMANY; INTESTINE TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PREDICTION AND FORECASTING; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INTESTINAL NEOPLASMS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREDNISOLONE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0042130357     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.026     Document Type: Article

References (56)

1. Domizio P, Owen R, Shepherd N, et al: Primary lymphoma of the small intestine: A clinicopathological study of 119 cases. Am J Surg Pathol 17:429-442, 1993
2. Radaszkiewicz T, Dragosics B, Bauer P: Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 102:1628-1638, 1992
3. Fischbach W, Dragosics B, Kolve-Goebeler M-E, et al: Primary gastric B-cell lymphoma: Results of a prospective multicenter study. Gastroenterology 119:1191-1202, 2000
4. Koch P, Valle FD, Berdel W, et al: Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma: Results of the prospective German Multicenter study GIT NHL 01/92. J Clin Oncol 19:3874-3883, 2001
5. Koch P, Valle FD, Berdel W, et al: Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter study GIT NHL 01/92. J Clin Oncol 19:3861-3873, 2001
6. Raderer M, Valencak J, Österreicher C, et al: Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor stages IE and IIE. Cancer 88:1979-1985, 2000
7. Steward W, Harris M, Wagstaff J, et al: A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract. Eur J Cancer Clin Oncol 21:1195-1200, 1985
8. Zinzani P, Magagnoli M, Pagliani G, et al: Primary intestinal lymphoma: Clinical and therapeutic features of 32 patients. Haematologica 82:305-308, 1997
9. Milanovic N, Jelic S, Jovanovic V, et al: Non IPSID small intestinal lymphoma: Evidence for disseminated disease at presentation. Neoplasma 41:359-362, 1994
10. Egan L, Walsh S, Stevens F, et al: Celiac-associated lymphoma: A single institution experience in the combination chemotherapy era. J Clin Gastroenterol 21:123-139, 1995
11. Chott A, Dragosics B, Radaszkiewicz T: Peripheral T-cell lymphomas of the intestine. Am J Pathol 141:1361-1371, 1992
12. Sanchez-Bueno F, Garcia-Marcilla J, Alonso J, et al: Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: A multivariate analysis of 76 cases. Eur J Surg 164:385-392, 1998
13. Shepherd N, Hall P, Coates P, et al: Primary malignant lymphoma of the colon and rectum: A histopathological analysis of 45 cases with clinicopathological correlations. Histopathology 12:235-252, 1988
14. Thomas J, Alladay M, Crawford D: Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res 57:329-380, 1991
15. Levine A: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20, 1992
16. DeMario M, Liebowitz D: Lymphomas in the immunocompromised patient. Semin Oncol 25:492-502, 1998
17. Loftus E, Tremaine W, Habermann T, et al: Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95:2308-2312, 2000
18. Harris N, Jaffe E, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
19. Isaacson P: Gastrointestinal lymphoma. Hum Pathol 25:1020-1029, 1994
20. Schmitt-Gräff A, Hummel M, Zemlin M, et al: Intestinal T-cell lymphoma: A reassessment of cytomorphological features in relation to patterns of small bowel remodelling. Virchows Arch 429:27-36, 1996
21. Harris NL, Jaffe ES, Diebold J, et al: Lymphoma classification: From controversy to consensus-The REAL and WHO classification of lymphoid neoplasms. Ann Oncol 11:3-10, 2000
22. Holmes G, Stokes P, Sorahan T, et al: Coeliac disease, gluten-free diet, and malignancy. Gut 17:612-619, 1976
23. Holmes G, Prior P, Lane M, et al: Malignancy in coeliac disease: Effect of a gluten free diet. Gut 30:333-338, 1989
24. Chott A, Haedicke W, Mosberger I, et al: Most CD56+ intestinal lymphomas are CD8+ CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153:1483-1490, 1998
25. Varghese C, Jose C, Subhashini J, et al: Primary small intestinal lymphoma. Oncology 49:340-342, 1992
26. Nakamura S, Matsumoto T, Takeshita M, et al: A clinicopathologic study of primary small intestine lymphoma. Cancer 88:286-294, 2000
27. d'Amore F, Brincker H, Ronbaek K, et al: Non-Hodgkin's lymphoma of the gastrointestinal tract: A population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. J Clin Oncol 12:1673-1684, 1994
28. Ibrahim E, Ezzat A, El-Weshi A, et al: Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 66 patients. Ann Oncol 12:53-58, 2001
29. Liang R, Todd D, Chan T, et al: Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol 13:153-163, 1995
30. Ruskoné-Fourmestraux A, Aegerter P, Delmer A, et al: Primary digestive tract lymphoma: A prospective multicentric study of 91 patients. Gastroenterology 105:1662-1671, 1993
31. Otter R, Bieger R, Kluin P, et al: Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 60:745-750, 1989
32. Gospodarowicz M, Sutcliffe S, Clark R, et al: Outcome analysis of localized gastrointestinal lymphoma treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys 19:1351-1355, 1990
33. Ha C, Cho M-J, Allen P, et al: Primary non-Hodgkin's lymphoma of the small bowel. Radiology 211:183-187, 1999
34. Bürgin-Wolff A, Gaze H, Haziselminovic F, et al: Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 66:941-947, 1991
35. Sulkanen S, Halttunen T, Laurila K, et al: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322-1328, 1998
36. Dieterich W, Laag E, Schopper H, et al: Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115:1317-1321, 1998
37. Walker-Smith J, Guandalini S, Schmitz J, et al: Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65:909-911, 1990
38. Musshoff K, Schmidt-Vollmer H: Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification. Z Krebsforsch 83:323-341, 1975
39. Ferguson A, Murray D: Quantitation of intraepithelial lymphocytes in human jejunum. Gut 12:988-994, 1971
40. Stein H, Gatter K, Asbahr H, et al: Use of freeze-dried paraffin embedded sections for immunohistological staining with monoclonal antibodies. Lab Invest 52:676-683, 1985
41. Dippel E, Assaf C, Hummel M: Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: A critical evaluation. J Pathol 188:146-154, 1999
42. Simon M, Kind P, Kaudewitz P, et al: Automated high-resolution polymerase chain reaction fragment analysis. Am J Pathol 152:29-33, 1998
43. Kaplan E, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
44. Ashton-Key M, Diss T, Pan L, et al: Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 151:493-498, 1997
45. Daum S, Weiss D, Hummel M, et al: Frequency of clonal intraepithelial T-lymphocyte proliferations in enteropathy-type intestinal T-cell lymphoma, celiac disease and refractory sprue. Gut 49:804-812, 2001
46. Mathus-Vliegen E, Halteren HV, Tytgat G: Malignant lymphoma in coeliac disease: Various manifestations with distinct symptomatology and prognosis. J Intern Med 236:43-49, 1994
47. Smith M: Non-Hodgkin's lymphoma. Curr Probl Cancer 20:6-77, 1996
48. Miller TP, Leblanc M, Spier C, et al: CHOP alone compared to CHOP plus radiotherapy for early aggressive Non-Hodgkin's lymphomas: Update of the Southwest Oncology Group randomized trial. Blood 98:724a-725a, 2001 (abstr)
49. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
50. Gale H, Simmonds P, Mead G, et al: Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol 18:795-803, 2000
51. Rodriguez J, Munsell M, Yazji S, et al: Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 19:3766-3770, 2001
52. Pellatt J, Sweetenham J, Swickering RM, et al: A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Ann Hematol 81:267-272, 2002
53. Melnyk A, Rodriguez A, Pugh WC, et al: Evaluation of the Revised European-American Lymphoma Classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 89:4514-4520, 1997
54. Howell W, Leung S, Jones D, et al: HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma: Common features and additional risk factors for malignancy. Hum Immunol 43:29-37, 1995
55. Cellier C, Delabesse E, Helmer C, et al: Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 356:203-208, 2000
56. Bagdi E, Diss T, Munson P, et al: Mucosal intraepithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 94:260-264, 1999